Eyeworld Supplements

ASCRS Clinical Survey 2017

This is a supplement to EyeWorld Magazine.

Issue link: https://supplements.eyeworld.org/i/890857

Contents of this Issue

Navigation

Page 4 of 15

Key findings Presbyopia-correcting IOLs account for 8% of cataract procedures. 28% of doctors do not use presbyopia- correcting IOLs at all, but 45% of this group said they plan on incorporating these options within the next year. The main reason for not using these advanced IOLs was cost to the patient (55%), but concern over quality of nighttime vision (36%) and a lack of confidence in the available technology (33%) were also cited as barriers, among other reasons. Of those using presbyopia-correcting IOLs, 66% of ophthalmologists obtain macular OCT preoperatively; U.S. physicians are more likely to do so compared to non-U.S. (77% vs. 55%, respectively). 13% of U.S. doctors do not obtain OCT preoperatively for these patients. Most (69%) reported 0.5 D of spherical deviation or less from intend- ed target as likely to have an impact on visual quality or patient satisfaction, while 8% think 1 D or more of spherical deviation is a threshold for visual significance. If an astigmatic patient wanted a multifocal IOL, which would require 1.25 D of cylinder, 49% of surgeons said they would implant a toric multifocal IOL. U.S. doctors are more than twice as likely to select manual LRIs or femtosecond laser-created AKs (33% compared to 25% of non-U.S. surgeons) and are three times as likely to se- lect a toric extended depth of focus IOL (19% compared to 6%). While most who use presbyopia-correcting IOLs do not mix and match (60%), 25% said they might do so with similar IOLs of different powers. Presbyopia correction 5 • 2017 ASCRS Clinical Survey

Articles in this issue

Archives of this issue

view archives of Eyeworld Supplements - ASCRS Clinical Survey 2017